All results

308 results

• A multicenter, open-label extension study to assess the long-term safety and tolerability of dapirol

  The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment. ### Inclusion Criteria: * The participant could,…

  Ages

  16 Years - N/A

  Sexes

  All

• A2AR and breathing in ALS

  The purpose of this research study is to determine the effects of a medication, istradefylline, in conjunction with breathing air with reduced oxygen for short…

  Ages

  21 Years - 80 Years

  Sexes

  All

• ABRuPT2

  This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid…

  Ages

  18 Years - N/A

  Sexes

  All

• ABX Nail Study

  This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those…

  Ages

  18 Years - N/A

  Sexes

  All

• ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)

  The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…

  Ages

  18 Years - N/A

  Sexes

  All

• AD Sleep Disturbance

  The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis. ### Inclusion…

  Ages

  18 Years - N/A

  Sexes

  All

• ADOPT PGx

  This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…

  Ages

  8 Years - N/A

  Sexes

  All

• AEVI-007

  The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease. ### Inclusion Criteria: 1.…

  Ages

  18 Years - 75 Years

  Sexes

  All

• AIM2ACT

  The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early…

  Ages

  12 Years - 70 Years

  Sexes

  All

• AL002 Feasibility Study for Treatment of Alzheimer s Disease

  The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB)…

  Ages

  50 Years - 85 Years

  Sexes

  All